FDA Approves Drug for Chronic Drooling in Children

The U.S. Food and Drug Administration today approved Cuvposa (glycopyrrolate) Oral Solution to treat chronic severe drooling caused by neurologic disorders in children ages 3 years to 16 years.

FDA Approves Drug for Chronic Drooling in Children